{
    "Trade/Device Name(s)": [
        "EUKARE Blood Glucose Monitoring System",
        "EUKARE Blood Glucose Test Strips",
        "EUKARE Blood Glucose Control Solution"
    ],
    "Submitter Information": "EUMED BIOTECHNOLOGY CO., LTD.",
    "510(k) Number": "K062892",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040678"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "January 22, 2007",
    "Summary Letter Received Date": "December 7, 2006",
    "Submission Date": "December 3, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Blood Glucose Test System-Over the counter"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "EUKARE glucose meter",
        "EUSURE glucose meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for EUKARE Blood Glucose Monitoring System and accessories using electrochemical biosensor for glucose measurement in capillary whole blood",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood for persons with diabetes at home or by health care professionals in clinical settings, not for neonatal use and for fingerstick specimens only",
    "fda_folder": "Clinical Chemistry"
}